Conmed (CNMD) Tops Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $32.58 +1.46%
Revenue Growth %: -0.5%
Financial Fact:
Selling and administrative expense: 79.01M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: -0.5%
Financial Fact:
Selling and administrative expense: 79.01M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Conmed (NYSE: CNMD) reported Q4 EPS of $1.07, $0.01 better than the analyst estimate of $1.06. Revenue for the quarter came in at $274 million versus the consensus estimate of $278.76 million.
GUIDANCE:
Conmed sees FY2022 EPS of $3.60-$3.85, versus the consensus of $3.74. Conmed sees FY2022 revenue of $1.075-1.125 billion, versus the consensus of $1.11 billion.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
- John Wiley & Sons, Inc. (WLY) Tops Q4 EPS by 12c; offers outlook
- John Wiley & Sons, Inc. (WLYB) Tops Q4 EPS by 12c; Offers Outlook
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
